{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:11:56Z","timestamp":1789654316900,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jpba.2015.10.008","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T11:16:03Z","timestamp":1445858163000},"page":"17-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Simultaneous determination of ceftaroline, daptomycin, linezolid and rifampicin concentrations in human plasma by on-line solid phase extraction coupled to high-performance liquid chromatography\u2013tandem mass spectrometry"],"prefix":"10.1016","volume":"118","author":[{"given":"M.","family":"Gr\u00e9goire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bouqui\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Malandain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Boutoille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Jolliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Caillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Deslandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2015.10.008_bib0005","unstructured":"European Centre for Disease Prevention and Control, EARSS Annual Reports."},{"key":"10.1016\/j.jpba.2015.10.008_bib0010","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa055356","article-title":"et EMERGEncy ID Net Study Group Methicillin-resistant S. aureus infections among patients in the emergency department","volume":"355","author":"Moran","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2015.10.008_bib0015","first-page":"626","article-title":"Reduced susceptibility of Staphylococcus aureus to vancomycin\u2014Japan, 1996","author":"Centers for Disease Control and Prevention (CDC)","year":"1997","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.jpba.2015.10.008_bib0020","first-page":"12","article-title":"Clinical pharmacokinetics of rifampicin","author":"Acocella","year":"1978","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jpba.2015.10.008_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/AAC.48.1.63-68.2004","article-title":"In vivo pharmacodynamic activity of daptomycin","volume":"48","author":"Safdar","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2015.10.008_bib0030","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1086\/652767","article-title":"Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis","volume":"50","author":"Bhavnani","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jpba.2015.10.008_bib0035","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/jac\/dks153","article-title":"Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients","volume":"67","author":"Pea","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2015.10.008_bib0040","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2165\/00003088-200342150-00007","article-title":"Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme","volume":"42","author":"Rayner","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jpba.2015.10.008_bib0045","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s10156-010-0080-6","article-title":"Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction","volume":"17","author":"Tsuji","year":"2011","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.jpba.2015.10.008_bib0050","first-page":"854","article-title":"Therapeutic drug monitoring in the treatment of tuberculosis: an update","author":"Alsultan et","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.jpba.2015.10.008_bib0055","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1128\/AAC.02531-14","article-title":"Pharmacokinetic\u2013pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections","volume":"59","author":"Bhavnani","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2015.10.008_bib0060","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1472-8206.2007.00490.x","article-title":"Lack of association between rifampicin plasma concentration and treatment-related side effects in osteoarticular infections","volume":"21","author":"Roblot","year":"2007","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2015.10.008_bib0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1515\/CCLM.2011.005","article-title":"Determination of daptomycin in human plasma by liquid chromatography\u2013tandem mass spectrometry. Clinical application","volume":"49","author":"Verdier","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jpba.2015.10.008_bib0070","first-page":"85","article-title":"Development and validation of an ultra performance liquid chromatography\u2013tandem mass spectrometry method for the quantification of daptomycin in human plasma","author":"Bazoti","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.10.008_bib0075","first-page":"212","article-title":"Simultaneous analysis of antibiotics in biological samples by ultra high performance liquid chromatography\u2013tandem mass spectrometry","author":"Cazorla-Reyes","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.10.008_bib0080","first-page":"76","article-title":"Simultaneous determination of selected chemotherapeutics in human whole blood by molecularly imprinted polymers coated solid phase microextraction fibers and liquid chromatography\u2013tandem mass spectrometry","author":"Szultka","year":"2013","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2015.10.008_bib0085","first-page":"603","article-title":"Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography\u2013tandem mass spectrometry","author":"Tsai","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2015.10.008_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2012.12.028","article-title":"Simultaneous quantitation of azole antifungals, antibiotics, imatinib, and raltegravir in human plasma by two-dimensional high-performance liquid chromatography\u2013tandem mass spectrometry","author":"Jourdil","year":"2013","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2015.10.008_bib0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chroma.2012.11.056","article-title":"A new approach for antibiotic drugs determination in human plasma by liquid chromatography\u2013mass spectrometry","author":"Szultka","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2015.10.008_bib0100","first-page":"2548","article-title":"A new way of solid-phase microextraction fibers preparation for selected antibiotic drug determination by HPLC-MS","author":"Olszowy","year":"2011","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2015.10.008_bib0105","first-page":"293","article-title":"Development and validation of a fast and uniform approach to quantify \u03b2-lactam antibiotics in human plasma by solid phase extraction-liquid chromatography-electrospray-tandem mass spectrometry","author":"Colin","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2015.10.008_bib0110","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/jac\/dkt154","article-title":"Method for simultaneous analysis of nine second-line anti-tuberculosis drugs using UPLC-MS\/MS","volume":"68","author":"Han","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2015.10.008_bib0115","first-page":"781","article-title":"Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS\/MS method with semi-automated sample preparation","volume":"53","author":"Zander","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jpba.2015.10.008_bib0120","article-title":"Quantification of piperacillin, tazobactam, meropenem, ceftazidime, and linezolid in human plasma by liquid chromatography\u2013tandem mass spectrometry","author":"Barco","year":"2014","journal-title":"J. Chemother."},{"key":"10.1016\/j.jpba.2015.10.008_bib0125","first-page":"16","article-title":"Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry","author":"Kim","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.10.008_bib0130","first-page":"82","article-title":"A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicin","author":"Hartkoorn","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2015.10.008_bib0135","first-page":"253","article-title":"Development and validation of liquid chromatography tandem mass spectrometry method for simultaneous quantification of first line tuberculosis drugs and metabolites in human plasma and its application in clinical study","author":"Hee","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.10.008_bib0140","first-page":"528","article-title":"Quantification of rifampicin in human plasma and cerebrospinal fluid by a highly sensitive and rapid liquid chromatographic\u2013tandem mass spectrometric method","author":"Srivastava","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.10.008_bib0145","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.jchromb.2009.04.038","article-title":"Simultaneous determination of clarithromycin, rifampicin and their main metabolites in human plasma by liquid chromatography\u2013tandem mass spectrometry","volume":"877","author":"de Velde","year":"2009","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2015.10.008_bib0150","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/rcm.2961","article-title":"Simultaneous determination of first-line anti-tuberculosis drugs and their major metabolic ratios by liquid chromatography\u2013tandem mass spectrometry","volume":"21","author":"Song","year":"2007","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2015.10.008_bib0155","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jpba.2013.09.006","article-title":"Simultaneous determination of probe drugs, metabolites, inhibitors and inducer in human plasma by liquid chromatography\u2013tandem mass spectrometry and its application to pharmacokinetic study","volume":"88","author":"Hee","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2015.10.008_bib0160","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1128\/AAC.02134-12","article-title":"Single- and multiple-dose study to determine thes afety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjects","volume":"57","author":"Riccobene","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2015.10.008_bib0165","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/sur.2014.098","article-title":"A pharmacokinetic\u2013pharmacodynamic analysis of ceftaroline prophylaxis in patients with external ventricular drains","volume":"16","author":"Stein","year":"2015","journal-title":"Surg. Infect. (Larchmt)"},{"key":"10.1016\/j.jpba.2015.10.008_bib0170","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration,Guidance for industry FDA, Bioanalytical Method Validation (2001)."},{"key":"10.1016\/j.jpba.2015.10.008_bib0175","unstructured":"European medicines agency, Guideline on bioanalytical method validation. (2012)."},{"key":"10.1016\/j.jpba.2015.10.008_bib0180","unstructured":"Comit\u00e9 fran\u00e7ais d'accr\u00e9ditation SH GTA 04. (2011)."},{"key":"10.1016\/j.jpba.2015.10.008_bib0185","first-page":"222","article-title":"Simultaneous determination of four immunosuppressants by means of high speed and robust on-line solid phase extraction-high performance liquid chromatography\u2013tandem mass spectrometry","author":"Koal","year":"2004","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515301825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515301825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T07:57:09Z","timestamp":1537257429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708515301825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":37,"alternative-id":["S0731708515301825"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2015.10.008","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous determination of ceftaroline, daptomycin, linezolid and rifampicin concentrations in human plasma by on-line solid phase extraction coupled to high-performance liquid chromatography\u2013tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2015.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}